Tenaya Therapeutics, Inc. (TNYA) Operating cash flow 2020–2025
Tenaya Therapeutics, Inc. (TNYA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$68.3MFY2025 · since FY2020: -$35.4M → -$68.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$68.3M | +24.6% |
| FY2024 | -$90.5M | +11.3% |
| FY2023 | -$102.1M | +2.3% |
| FY2022 | -$104.4M | -71.7% |
| FY2021 | -$60.8M | -71.6% |
| FY2020 | -$35.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TNYA financial trends
TNYA RevenueTNYA Net incomeTNYA Net marginTNYA Gross profitTNYA Gross marginTNYA Operating incomeTNYA Operating marginTNYA Free cash flowTNYA Capital expendituresTNYA Return on equityTNYA Stock buybacksTNYA Dividends paidTNYA Total assetsTNYA Total liabilitiesTNYA Shareholders’ equityTNYA overview →